InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Townson Sharon. Director active across 1 company, notably Monte Rosa Therapeutics, Inc.. Aggregated, 7 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €122k. History available since 6 July 2026. The latest transaction was filed on 6 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Townson Sharon is a declarant linked to Monte Rosa Therapeutics, Inc., where the listed role is Chief Scientific Officer. She has 7 filings in total, and across the 7 sampled filings, the recorded transactions run from 2025-01-06 to 2026-07-07, with EUR 0 in buys and EUR 122270 in sells; the modal transaction nature is Disposal.